Hims & Hers Health, Inc. (NYSE:HIMS) Receives $37.23 Average Price Target from Analysts
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has been assigned a consensus recommendation of “Hold” from the fifteen brokerages that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and six have issued a buy […]
